Close Menu

This article has been updated with additional information from Bionano's earnings call.

NEW YORK (GenomeWeb) – Bionano Genomics reported after the close of the market on Thursday a 41 percent year-over-year increase in its fourth quarter revenues, the company's first full quarter as a publicly traded firm.

Separately, the firm said it has entered into two separate debt and equity financing agreements totaling $41.5 million with Innovatus Life Sciences Lending Fund, East West Bank, and Aspire Capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.